ADAPTIVE BIOTECHNOLOGIES CORPORATION - COMMON STOC

Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results

03 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

28 июл 2022 07:30:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022

08 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease

15 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology

02 июн 2022 16:10:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

26 май 2022 08:00:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2022 Financial Results

04 май 2022 16:05:03 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference

02 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022

05 апр 2022 16:30:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas

09 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the 42nd Annual Cowen Healthcare Conference

02 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease

18 фев 2022 11:35:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results

15 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022

24 янв 2022 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition

10 янв 2022 08:30:00 Источник Nasdaq GlobeNewswire

Updated: Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

04 янв 2022 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

29 дек 2021 08:00:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting

13 дек 2021 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting

02 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire